Comments
Loading...
LeanLife Health Analyst Ratings and Price Targets | OTC:LNLHF | Benzinga
LeanLife Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for LeanLife Health Corp from these most-recent analyst ratings.
Analyst Ratings for LeanLife Health
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for LeanLife Health (LNLHF) stock?
There is no price target for LeanLife Health
What is the most recent analyst rating for LeanLife Health (LNLHF)?
There is no analyst for LeanLife Health
When was the last upgrade for LeanLife Health (LNLHF)?
There is no last upgrade for LeanLife Health
When was the last downgrade for LeanLife Health (LNLHF)?
There is no last downgrade for LeanLife Health.
When is the next analyst rating going to be posted or updated for LeanLife Health (LNLHF)?
There is no next analyst rating for LeanLife Health.
Is the Analyst Rating LeanLife Health (LNLHF) correct?
There is no next analyst rating for LeanLife Health.
Browse analyst ratings and price targets on all stocks.